z-logo
open-access-imgOpen Access
Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes
Author(s) -
Stuart L. Schreiber,
Joanne Kotz,
Min Li,
Jeffrey Aubé,
Christopher P. Austin,
John C. Reed,
Hugh Rosen,
E. Lucile White,
Larry A. Sklar,
Craig W. Lindsley,
Benjamin Alexander,
Joshua A. Bittker,
Paul A. Clemons,
Andrea de Souza,
Michael Foley,
Michelle Palmer,
Alykhan F. Shamji,
Mathias J. Wawer,
Owen B. McManus,
Meng Wu,
Beiyan Zou,
Haibo Yu,
Jennifer E. Golden,
Frank J. Schoenen,
Anton Simeonov,
Ajit Jadhav,
Michael R. Jackson,
Anthony B. Pinkerton,
Thomas D.Y. Chung,
Patrick R. Griffin,
Benjamin F. Cravatt,
Peter Hodder,
William Roush,
Edward Roberts,
Dong-Hoon Chung,
Colleen B. Jonsson,
James W. Noah,
William E. Severson,
Subramaniam Ananthan,
Bruce S. Edwards,
Tudor I. Oprea,
P. Jeffrey Conn,
Corey R. Hopkins,
Michael R. Wood,
Shaun R. Stauffer,
Kyle A. Emmitte,
Linda S. Brady,
Jamie Driscoll,
Ingrid Y. Li,
Carson R. Loomis,
Ron Margolis,
Enrique L. Michelotti,
Mary Ellen Perry,
Ajay Pillai,
Yong Yao
Publication year - 2015
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2015.05.023
Subject(s) - small molecule , biology , computational biology , drug discovery , nanotechnology , data science , bioinformatics , computer science , genetics , materials science
Small-molecule probes can illuminate biological processes and aid in the assessment of emerging therapeutic targets by perturbing biological systems in a manner distinct from other experimental approaches. Despite the tremendous promise of chemical tools for investigating biology and disease, small-molecule probes were unavailable for most targets and pathways as recently as a decade ago. In 2005, the NIH launched the decade-long Molecular Libraries Program with the intent of innovating in and broadening access to small-molecule science. This Perspective describes how novel small-molecule probes identified through the program are enabling the exploration of biological pathways and therapeutic hypotheses not otherwise testable. These experiences illustrate how small-molecule probes can help bridge the chasm between biological research and the development of medicines but also highlight the need to innovate the science of therapeutic discovery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom